Literature DB >> 33579016

Lysozyme Fibrils Alter the Mechanism of Insulin Amyloid Aggregation.

Mantas Ziaunys1, Andrius Sakalauskas1, Tomas Sneideris1,2, Vytautas Smirnovas1.   

Abstract

Protein aggregation into amyloid fibrils is linked to multiple disorders. The understanding of how natively non-harmful proteins convert to these highly cytotoxic amyloid aggregates is still not sufficient, with new ideas and hypotheses being presented each year. Recently it has been shown that more than one type of protein aggregates may co-exist in the affected tissue of patients suffering from amyloid-related disorders, sparking the idea that amyloid aggregates formed by one protein may induce another protein's fibrillization. In this work, we examine the effect that lysozyme fibrils have on insulin amyloid aggregation. We show that not only do lysozyme fibrils affect insulin nucleation, but they also alter the mechanism of its aggregation.

Entities:  

Keywords:  aggregation mechanism; amyloid aggregation; insulin fibrils; lysozyme fibrils

Mesh:

Substances:

Year:  2021        PMID: 33579016      PMCID: PMC7916790          DOI: 10.3390/ijms22041775

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  39 in total

1.  Cross-seeding effects of amyloid β-protein and α-synuclein.

Authors:  Kenjiro Ono; Ryoichi Takahashi; Tokuhei Ikeda; Masahito Yamada
Journal:  J Neurochem       Date:  2012-07-23       Impact factor: 5.372

2.  Environmental conditions affect the kinetics of nucleation of amyloid fibrils and determine their morphology.

Authors:  Bertrand Morel; Lorena Varela; Ana I Azuaga; Francisco Conejero-Lara
Journal:  Biophys J       Date:  2010-12-01       Impact factor: 4.033

Review 3.  Type 2 diabetes as a protein misfolding disease.

Authors:  Abhisek Mukherjee; Diego Morales-Scheihing; Peter C Butler; Claudio Soto
Journal:  Trends Mol Med       Date:  2015-05-18       Impact factor: 11.951

Review 4.  Secondary nucleation in amyloid formation.

Authors:  Mattias Törnquist; Thomas C T Michaels; Kalyani Sanagavarapu; Xiaoting Yang; Georg Meisl; Samuel I A Cohen; Tuomas P J Knowles; Sara Linse
Journal:  Chem Commun (Camb)       Date:  2018-08-02       Impact factor: 6.222

5.  Soluble prion protein inhibits amyloid-β (Aβ) fibrillization and toxicity.

Authors:  Krzysztof Nieznanski; Jin-Kyu Choi; Shugui Chen; Krystyna Surewicz; Witold K Surewicz
Journal:  J Biol Chem       Date:  2012-08-22       Impact factor: 5.157

6.  Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

Authors:  Liesi E Hebert; Jennifer Weuve; Paul A Scherr; Denis A Evans
Journal:  Neurology       Date:  2013-02-06       Impact factor: 9.910

7.  Amyloid-β Peptide Induces Prion Protein Amyloid Formation: Evidence for Its Widespread Amyloidogenic Effect.

Authors:  Ryo Honda
Journal:  Angew Chem Int Ed Engl       Date:  2018-04-23       Impact factor: 15.336

Review 8.  Mechanisms of Strain Diversity of Disease-Associated in-Register Parallel β-Sheet Amyloids and Implications About Prion Strains.

Authors:  Yuzuru Taguchi; Hiroki Otaki; Noriyuki Nishida
Journal:  Viruses       Date:  2019-01-28       Impact factor: 5.048

9.  Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.

Authors:  Tomas Sneideris; Mantas Ziaunys; Brett K-Y Chu; Rita P-Y Chen; Vytautas Smirnovas
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

10.  The Environment Is a Key Factor in Determining the Anti-Amyloid Efficacy of EGCG.

Authors:  Tomas Sneideris; Andrius Sakalauskas; Rebecca Sternke-Hoffmann; Alessia Peduzzo; Mantas Ziaunys; Alexander K Buell; Vytautas Smirnovas
Journal:  Biomolecules       Date:  2019-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.